Shimadzu and AHRA Education Foundation announce five-year partnership

Shimadzu Medical Systems USA and the AHRA Education Foundation are pleased to announce a five year partnership extending through 2017 as part of the foundation’s Expanding Excellence Campaign.

Shimadzu has been a longtime supporter of AHRA in advancing the medical imaging industry, but in 2013 the corporation surpassed all historic levels of investment in the AHRA Foundation, pledging a total of $102,200 for the five year period. With a commitment at the three star partnership level, Shimadzu joins other leading corporate partners in the top tier of the campaign.

The AHRA Expanding Excellence Campaign has been an unprecedented fundraising effort that surpassed its $3,000,000 goal by raising a total of $3,168,375. Several corporations and many AHRA members made commitments to the AHRA Educational Foundation to support of world class education and research initiatives in the imaging management profession.

“Developing partnerships with industry leaders such as Shimadzu is truly a great opportunity for us all to work together in advancing the profession. I look forward to our partnership objectives being realized in the next five years and developing our relationship even further into the future,” commented the chair of the foundation, Luann Culbreth.

Frank Serrao, Shimadzu’s marketing manager for North America said, “Shimadzu Medical Systems has always supported the AHRA, its organization and its goals to educate the imaging community. We feel that partnered formally (AHRA and Shimadzu) only strengthens our resolve to work side-by-side with healthcare professionals and our cutting edge technology for vastly improving the patient experience.”

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.